scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12020-010-9333-5 |
P698 | PubMed publication ID | 20960164 |
P50 | author | José B Fariña | Q54900782 |
Ana Santoveña | Q60172421 | ||
P2093 | author name string | Carmen J Booth | |
Shilpa Patel | |||
Michael E Hodsdon | |||
Syrus Meshack | |||
Alexis Oliva | |||
Priscilla S Dannies | |||
Yonglian Zhu | |||
Matias Llabrés | |||
P2860 | cites work | Cancer statistics, 2006 | Q29615133 |
Friends or foes - bipolar effects of the tumour stroma in cancer | Q29619348 | ||
Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations--preliminary MR imaging in rats | Q31152219 | ||
Current diagnosis and treatment modalities for ovarian cancer | Q34483859 | ||
SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions | Q34577903 | ||
The dominance of the microenvironment in breast and ovarian cancer | Q34654993 | ||
Treatment of ovarian cancer: new strategies | Q35202999 | ||
Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View | Q35577251 | ||
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer | Q35747792 | ||
Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization | Q35753569 | ||
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. | Q35899034 | ||
Estrogen regulation of growth hormone action. | Q35910110 | ||
Protein energetics in maturation of the early secretory pathway. | Q36905308 | ||
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice | Q37012122 | ||
Early events in the pathogenesis of epithelial ovarian cancer | Q37057044 | ||
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer | Q38297653 | ||
Zinc mediation of the binding of human growth hormone to the human prolactin receptor | Q38337737 | ||
Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest | Q38342782 | ||
A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. | Q40458790 | ||
Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity | Q40598798 | ||
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. | Q40793154 | ||
Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. | Q40896850 | ||
Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. | Q41573546 | ||
Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes | Q41716023 | ||
Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis | Q42063094 | ||
Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic | Q43798616 | ||
Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer | Q44086971 | ||
Increases in weight of growth hormone‐deficient and immunodeficient (lit/scid) dwarf mice after grafting of hGH‐ secreting, primary human keratinocytes | Q44606542 | ||
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy | Q44785625 | ||
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. | Q45863608 | ||
Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production | Q45865294 | ||
Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. | Q45868863 | ||
Inefficient secretion of human H27A-prolactin, a mutant that does not bind Zn2+. | Q48632095 | ||
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer | Q57037912 | ||
Histological assessment of the mouse uterus from birth to puberty for the appearance of LGL-1+ natural killer cells | Q67550447 | ||
Human Growth Hormone Binds to Lactogenic Receptors in Bovine, Ovine and Rat Adrenals | Q68467179 | ||
Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice | Q69083418 | ||
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support | Q69496423 | ||
Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa | Q71959849 | ||
An immunohistologic analysis of murine uterine T cells between birth and puberty | Q72876984 | ||
Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I | Q73047906 | ||
Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources | Q73374387 | ||
Identification of a motif associated with the lactogenic actions of human growth hormone | Q73596260 | ||
Characterization of human ovarian carcinomas in a SCID mouse model | Q74447100 | ||
IGF-I in epithelial ovarian cancer and its role in disease progression | Q80597785 | ||
ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice | Q80752705 | ||
Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts | Q80761070 | ||
Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells | Q81652515 | ||
Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer | Q95761845 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 430-439 | |
P577 | publication date | 2010-04-20 | |
P1433 | published in | Endocrine | Q15757048 |
P1476 | title | Anti-tumor effects of adenovirus containing human growth hormone sequences in a mouse model of human ovarian cancer | |
P478 | volume | 37 |
Q38022486 | Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. |
Q34358402 | Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon |
Q33556564 | Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines |
Search more.